Production of monoclonal antibodies (mAb) is a well-known method to synthesize a large number of identical antibodies, of huge importance in medicine. In thus context, huge efforts have been spent to maximize the mAb production in industrial bioreactors by using hybridoma cell cultures. However, the optimal operation of these bioreactors is an engineering problem difficult to solve due to the highly nonlinear bioprocess dynamics, and a bioreactor involving a large number of decision (control) variables, subjected to multiple nonlinear process constraints, which often translates into a non-convex optimization problem. Based on an adequate kinetic model adopted from literature, this paper is aiming at in-silico, off-line deriving and comparing the optimal operating policies of a batch bioreactor (BR), and a fed-batch bioreactor (FBR) operated in several feeding alternatives (including substrates and the viable biomass) with using a hybridoma culture immobilized on a porous support (alginate) for mAb production. FBR with a variable time stepwise optimal feeding policy proved to reach better performances in terms of mAb production maximization with a minimal raw-material consumption.
Read full abstract